Ascendis Pharma stock forecast
Ascendis Pharma (ASND1N) Stock Forecast & Price Target
ASND1N Analyst Ratings
ASND1N Stock 12 Month Forecast
Average Price Target
Mex$5,938▲(42.55% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Eliana Merle | Barclays | Mex$6,105→Mex$6,328 | buy | 51.91%Upside | Reiterated | 11/16/26 | ||
| Eric Joseph | Citi | Mex$6,124→Mex$6,216 | buy | 49.24%Upside | Reiterated | 11/16/26 | ||
| Yaron Werber | TD Cowen | Mex$6,328→Mex$6,532 | buy | 56.81%Upside | Reiterated | 11/13/26 | ||
| Mitchell Kapoor | H.C. Wainwright | Mex$6,383→Mex$6,216 | buy | 49.24%Upside | Reiterated | 11/13/26 | ||
| Gary Nachman | Canaccord Genuity | Mex$4,973→Mex$5,085 | hold | 22.06%Upside | Reiterated | 11/13/26 | ||
| Derek Archila | Wells Fargo | Mex$6,049→Mex$6,124 | buy | 47.01%Upside | Reiterated | 11/13/26 | ||
| Joon Lee | UBS | Mex$4,992→Mex$5,845 | buy | 40.33%Upside | Assigned | 11/13/26 | ||
| Yun Zhong | Wedbush | Mex$6,068→Mex$6,421 | buy | 54.14%Upside | Reiterated | 11/13/26 | ||
| Gavin Clark-Gartner | Evercore ISI | Mex$6,049→Mex$6,606 | buy | 58.59%Upside | Reiterated | 11/13/26 | ||
| Maxwell Skor | Morgan Stanley | Mex$5,066→Mex$5,604 | buy | 34.53%Upside | Reiterated | 11/13/26 | ||
| Joseph Schwartz | Leerink Partners | Mex$6,049 | buy | 45.23%Upside | Reiterated | 11/13/26 | ||
| Tazeen Ahmad | Bank of America Securities | Mex$5,641 | buy | 35.43%Upside | Reiterated | 11/12/26 | ||
| Luca Issi | RBC Capital | Mex$5,381 | buy | 29.19%Upside | Reiterated | 11/12/26 | ||
| Jessica Fye | J.P. Morgan | ― | buy | ― | Reiterated | 10/10/26 | ||
| Li Watsek | Cantor Fitzgerald | Mex$5,567 | buy | 33.64%Upside | Reiterated | 09/25/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Eliana MerleBarclays | BuyReiteratedMex$6,105→Mex$6,328 | 11/16/26 | 51.91%Upside | ||
| Eric JosephCiti | BuyReiteratedMex$6,124→Mex$6,216 | 11/16/26 | 49.24%Upside | ||
| Yaron WerberTD Cowen | BuyReiteratedMex$6,328→Mex$6,532 | 11/13/26 | 56.81%Upside | ||
| Mitchell KapoorH.C. Wainwright | BuyReiteratedMex$6,383→Mex$6,216 | 11/13/26 | 49.24%Upside | ||
| Gary NachmanCanaccord Genuity | HoldReiteratedMex$4,973→Mex$5,085 | 11/13/26 | 22.06%Upside | ||
| Derek ArchilaWells Fargo | BuyReiteratedMex$6,049→Mex$6,124 | 11/13/26 | 47.01%Upside | ||
| Joon LeeUBS | BuyAssignedMex$4,992→Mex$5,845 | 11/13/26 | 40.33%Upside | ||
| Yun ZhongWedbush | BuyReiteratedMex$6,068→Mex$6,421 | 11/13/26 | 54.14%Upside | ||
| Gavin Clark-GartnerEvercore ISI | BuyReiteratedMex$6,049→Mex$6,606 | 11/13/26 | 58.59%Upside | ||
| Maxwell SkorMorgan Stanley | BuyReiteratedMex$5,066→Mex$5,604 | 11/13/26 | 34.53%Upside | ||
| Joseph SchwartzLeerink Partners | BuyReiteratedMex$6,049 | 11/13/26 | 45.23%Upside | ||
| Tazeen AhmadBank of America Securities | BuyReiteratedMex$5,641 | 11/12/26 | 35.43%Upside | ||
| Luca IssiRBC Capital | BuyReiteratedMex$5,381 | 11/12/26 | 29.19%Upside | ||
| Jessica FyeJ.P. Morgan | BuyReiterated | 10/10/26 | ― | ||
| Li WatsekCantor Fitzgerald | BuyReiteratedMex$5,567 | 09/25/26 | 33.64%Upside |
Best Analysts Covering Ascendis Pharma
Copying Alex Thompson CFA's trades and holding each position for 3 Months would result in 93.33% of your transactions generating a profit, with an average return of +7.71% per trade.
Copying Alex Thompson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +35.70% per trade.
Copying Paul Choi's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +68.86% per trade.
ASND1N Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 27 | 37 | 47 | 50 | 42 |
| Hold | 0 | 0 | 0 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 27 | 37 | 47 | 51 | 44 |
In the current month, ASND1N has received 42 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ASND1N average Analyst price target in the past 3 months is 5,938.13.
ASND1N Financial Forecast
ASND1N Earnings Forecast
Next quarter’s earnings estimate for ASND1N is MXN 33.13 with a range of MXN 4.29 to MXN 46.22. The previous quarter’s EPS was MXN 22.09. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ASND1N Sales Forecast
Next quarter’s sales forecast for ASND1N is MXN 8.45B with a range of MXN 7.73B to MXN 8.90B. The previous quarter’s sales results were MXN 7.89B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

